Neurosurgery

【Growth Process】

In 1986, our hospital performed the first craniocerebral trauma surgery (main performer: Yu Haicai). In 1987, our hospital performed the first spontaneous cerebral hemorrhage surgery (main performer: Yu Haicai). In 1990, Fuyang No. 1 Hospital established the Department of Neurosurgery. , has successively combined wards with orthopedics and oncology surgery. Fuyang No. 1 Hospital introduced the first spiral CT to provide equipment support for the development of neurosurgery. Surgery has moved from general medical care to specialized medical care, and the goal of specialist development has been determined. In 1994, the first brain tumor surgery was performed (mainly performed by Mao Wei). In 1996, the first ventriculoperitoneal shunt was performed (mainly performed by Mao Wei). In 1997, the first intracranial pressure probe implantation was performed. Surgery (main developer: Yang Weilin). In 1999, the first microvascular decompression surgery for trigeminal neuralgia was performed (main developer: Qiu Shenzhong). In 2000, small bone window minimally invasive treatment of cerebral hemorrhage was performed (main developer: Qiu Shenzhong). In 2006, The first case of cerebral vascular reconstruction with temporalis muscle application and dura mater reflection was carried out (main operator: Qiu Shenzhong). In December 2008, the Neurosurgery Department established an independent ward, and Qiu Shenzhong served as the director of the Department of Neurosurgery, focusing on the comprehensive development of clinical, teaching, and scientific research. After several generations of unremitting efforts, the department has reached the leading level of county-level hospitals in the comprehensive development of medical care, teaching, scientific research and other disciplines, and is now a key medical discipline in Fuyang District. In 2012, the Hangzhou Regional Co-constructed Discipline introduced specialized microscopes for neurosurgery. Under the leadership of Director Qiu Shenzhong, the neurosurgery technology was raised to a new level, and minimally invasive surgery under the microscope was gradually carried out to treat cerebral hemorrhage and brain tumors. In 2013, the first case of cerebral aneurysm clipping was performed (mainly performed by Qiu Shenzhong and Shen Jia). In 2014, under the leadership of Director Qiu Shenzhong, intracranial pressure monitoring and mild hypothermia treatment were carried out, and the treatment of severe craniocerebral injuries was standardized and Precision. Established the first round of key medical disciplines in Fuyang District, co-organized the Hangzhou Neurosurgery Annual Conference, and held Hangzhou continuing education classes. In 2015, the first whole-brain angiography was performed (main performer: Shen Jia). The first case of interventional embolization for cerebrovascular disease was performed (main performer: Shen Jia). The second Hangzhou continuing education class was held. In 2016, the first transnasal sphenoidal pituitary tumor resection was performed (main performer: Qiu Shenzhong). Cerebral vascular reconstruction, transnasal sphenoidal pituitary tumor resection, skull base tumor resection, spinal canal tumor resection and other difficult surgeries have been carried out successively. In 2017, the first simple stereotactic surgery was performed (main performer: Qiu Shenzhong). Under the leadership of Director Qiu Shenzhong, the business volume and technical level of neurosurgery have been improved to new levels. CT cross-reference software combined with MARK definition 3Dslicer software combined with mobile phone positioning has been gradually applied to various neurosurgery operations, and minimally invasive surgeries for cerebral hemorrhage and brain tumors have been comprehensively improved. In 2018, the first case of carotid endarterectomy and the first case of interventional targeted therapy for brain tumors were performed (main developer: Qiu Shenzhong). Interventional minimally invasive treatments for various cerebrovascular diseases (interventional technology has been vigorously developed), microvascular decompression for trigeminal neuralgia and hemifacial spasm, endarterectomy and stent implantation for carotid artery stenosis, and interventional targets for brain tumors have been gradually carried out. Focusing on treatment, multiple SCI papers have been published at the same time, and multiple department-level projects have been approved or accepted. The comprehensive strength of neurosurgery has been greatly improved. Various technologies are at the forefront of hospitals at the same level in Hangzhou. From 2019 to 2020, the first case of microvascular decompression for hemifacial spasm and endoscopic minimally invasive treatment of cerebral hemorrhage was carried out. (Main developers: Chen Bin, Qiu Shenzhong). The first surgical robot-assisted brainstem hematoma puncture and drainage was performed. (Developed by: Qiu Shenzhong, Huang Jianjun, Zheng Guanrong). The first stereotactic brain tumor biopsy was performed. (Developed by: Qiu Shenzhong, Zheng Guanrong) From 2021 to 2023, with the help of famous doctor Luo Chun, we will routinely carry out treatments for skull base tumors, petroclival area tumors, acoustic neuromas, brainstem, cerebellar arteriovenous malformations, complex dural arteriovenous fistulas, etc. Extremely difficult surgery. In 2022, it was rated as a neurosurgery construction center by the National Health Commission. Very difficult surgeries such as pulse fistula. In 2022, it was rated as a neurosurgery construction center by the National Health Commission. Very difficult surgeries such as pulse fistula. In 2022, it was rated as a neurosurgery construction center by the National Health Commission.

[Successively served as diagnosis and treatment team leader, director, and head nurse]

From 1990 to 1994, department director Yu Haicai and head nurse Shen Zhouxiang were the pioneers of surgery and the founder of neurosurgery in our hospital. Under their leadership, Fuyang District People's Hospital opened a new chapter in neurosurgery. From 1994 to 2008, department director Mao Wei and head nurses Chen Wenying and Zhang Jianying led the department's medical staff to gradually carry out routine neurosurgery operations such as craniocerebral trauma, spontaneous cerebral hemorrhage, and brain tumors, laying the foundation for the development of neurosurgery. From 2008 to present, Qiu Shenzhong serves as the department director, Shen Jia serves as the deputy director, and successively serve as head nurses Zhang Jianying, Dong Xiaoya, and Chen Suping. During this period, clinical practice, scientific research, and teaching developed comprehensively, and a large number of new technologies and new projects and difficult surgeries were carried out, and neurosurgery entered the era of minimally invasive surgical treatment. Pay attention to scientific research topics and the publication of high-quality papers. Organize multiple continuing education classes.

【Current status of subject】

Neurosurgery was founded in 1990. It is a regional co-constructed discipline in Hangzhou and a key medical discipline in Fuyang District. It has established a doctoral workstation and the famous doctor Luo Chun's studio. The department has 50 open beds and currently has 8 doctors, 2 chief physicians, 3 deputy chief physicians, 1 attending physician and 2 resident physicians. 2 master students and 1 working graduate student. The department is characterized by the integrated treatment of severe craniocerebral injuries, including emergency, critical care, and rehabilitation. It focuses on minimally invasive treatment of intracerebral hemorrhage under neuroendoscopy and microscopy, microsurgical treatment of brain tumors, and interventional and clipping surgery for cerebrovascular disease. The hospital discharges about 1,200 people annually and performs about 400 surgeries annually. Its scale is unprecedented among county-level hospitals in the province. It has hosted Hangzhou continuing education classes for many times and once hosted the Hangzhou Neurosurgery Annual Conference. In recent years, one project from the Provincial Department of Health, two projects from the Hangzhou Municipal Science and Technology Bureau, two projects from the Hangzhou Municipal Health Bureau, three projects from the Fuyang District Science and Technology Bureau and one project from the Zhejiang Preventive Medicine Association have been approved or accepted. Published 9 SCI papers and more than 30 papers in first- and second-level journals. Minimally invasive treatment of hypertensive cerebral hemorrhage under a microscope, accurate intracranial pressure monitoring, and integrated treatment of severe craniocerebral injuries are the highlights of our department. Using the doctoral workstation and Luo Chun famous doctor studio platform, transnasal sphenoidal pituitary tumor resection, carotid endarterectomy, intracranial aneurysm clipping, spinal canal tumor resection, trigeminal neuralgia, and hemifacial spasm microvascular reduction Compression surgery, skull base tumor resection, petroclival area tumors, acoustic neuroma resection, brain stem, cerebellar arteriovenous malformation, complex dural arteriovenous fistula and complex intracranial aneurysm interventional embolization and other difficult surgeries. The subject leader is the national committee member of the Neurological Injury Group of the Trauma Branch of the Chinese Medical Association. The department is a unit of the Neurosurgery Alliance of the Second Hospital of Zhejiang University and the First Hospital of Zhejiang University, a unit of the Neurorehabilitation Alliance of the First Hospital of Zhejiang University, and the famous doctor studio of Tongji Hospital Affiliated to Tongji University in Shanghai. It was rated as a neurosurgery construction center by the National Health Commission.

【Diagnosis and treatment scope】

Carry out integrated treatment of severe craniocerebral injury first aid, critical illness, and rehabilitation (hyperbaric oxygen, acupuncture, physiotherapy, exercise therapy). Endoscopic, microscopic and stereotactic microsurgery for the treatment of cerebral hemorrhage, cerebrovascular disease intervention and surgical clipping. Carry out microsurgery for meningiomas, gliomas, pituitary tumors and spinal canal tumors, carotid endarterectomy + vascular reconstruction, microvascular decompression for trigeminal neuralgia, hemifacial spasm, skull base tumor resection, petrosclival surgery Tumor, acoustic neuroma resection, brainstem, cerebellar arteriovenous malformation, complex dural arteriovenous fistula and complex intracranial aneurysm interventional embolization and other difficult surgeries. VP shunt for hydrocephalus after brain trauma, skull repair, hyperbaric oxygen therapy, etc.

【Technical Features】

Neurosurgery currently has high-precision medical equipment such as Zeiss operating microscopes, ventriculoscopes, intracranial pressure monitors, craniotomy power systems, DSA machines, hyperbaric oxygen chambers, and 64-slice spiral CTs. Carry out integrated treatment of severe craniocerebral injury and hypertensive cerebral hemorrhage, in line with international standards, and achieve standardization and advancement. Stereotactic minimally invasive treatment for functional area cerebral hemorrhage and brain tumors, interventional minimally invasive treatment for cerebrovascular disease, and interventional targeted therapy for glioblastoma. Various surgeries performed in our department have entered the minimally invasive era. Carotid artery B-ultrasound screening is carried out, and patients with severe stenosis and ischemic symptoms undergo carotid artery intimal stent implantation and endarterectomy. Microvascular decompression is performed for trigeminal neuralgia and hemifacial spasm. Our department comprehensively carries out various neurosurgery operations such as trauma, vascular disease, tumor, and functional surgery, following the principles of standardization, precision, and minimal invasiveness.

【Scientific research results】

Our department is responsible for one provincial health department project and a number of Hangzhou city department and bureau-level subjects. The whole department publishes several papers in SCI journals and core journals (including the "China" series of journals) every year. Many people from our department participate in domestic academic conferences at all levels every year, and actively participate through conference speeches, exhibition boards and paper exchanges. Domestic academic activities have brought advanced medical concepts and diagnostic and treatment technologies at home and abroad back to the department, and have been successively applied in clinical practice, achieving good results.